Genotropin Study Assessing Use of Injection Pen
NCT00965484
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
136
Enrollment
INDUSTRY
Sponsor class
Conditions
Growth Hormone Deficiency
Idiopathic Short Stature
Interventions
DEVICE:
New Genotropin Pen
Sponsor
Pfizer